Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin

Soft-tissue sarcomas (STS) are a heterogeneous group of rare solid tumors of mesenchymal origin. This paper reviews the current status of systemic treatment in advanced and metastatic soft tissue sarcomas, with an emphasis on trabectedin. Trabectedin is a unique type of chemotherapeutic agent with m...

Descripción completa

Detalles Bibliográficos
Autores principales: Desar, Ingrid M E, Constantinidou, Anastasia, Kaal, Suzanne E J, Jones, Robin L, van der Graaf, Winette T A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993282/
https://www.ncbi.nlm.nih.gov/pubmed/27574465
http://dx.doi.org/10.2147/CMAR.S86746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993282/
https://www.ncbi.nlm.nih.gov/pubmed/27574465
http://dx.doi.org/10.2147/CMAR.S86746

Ejemplares similares